Rare
lephants
Knowledge
Value Investing
What is Value Investing?
What Is a Moat?
Intangible Assets
Cost Advantage
Pricing Power
Network Effect
Switching Costs
Efficient Scale
Intrinsic Value
Margin of Safety
Circle of Competence
Mr. Market
ROIC
Financial Statements
Income Statement
High Gross Margins
R&D Spending
Sales & Marketing
Net Margin
Balance Sheet
Long-Term Debt
Float
Receivables/Payables
Derivatives
Cash Flow Statement
Free Cash Flow
Shareholder Returns
Cap Ex
Stock-Based Compensation
Berkshire Hathaway Lessons
The Four Criteria — 1977
Rare Fast-Moving Elephants — 1987
Mr. Market — 1987
Wonderful Companies at Fair Prices — 1989
Risk Isn’t Volatility — 1993
Circle of Competence — 1996
Swimming Naked — 2001
“Price Is What You Pay...” — 2008
Famous Value Investors
Benjamin Graham
Warren Buffett
Charlie Munger
Phil Fisher
Peter Lynch
Howard Marks
Screener
Beta
Toggle theme
Ernexa Therapeutics Inc.
ERNAW
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Share-Based Metrics
Valuation
Profit History
Profit Flow
Profit Margins
Returns on Capital
Profitability
›
Profit Flow
Profit Flow
FY2024
FY2024
FY2024
FY2023
FY2020
FY2020
FY2020
FY2019
FY2019
FY2019
FY2018
FY2018
FY2018
FY2017
FY2017
FY2017
FY2016
FY2016
FY2016
FY2015
FY2015
FY2015
FY2014
FY2014
FY2014
FY2013
FY2013
FY2013
FY2012
FY2012
FY2012
FY2012
FY2011
FY2011
FY2011
FY2011
FY2010
FY2010
